Team NEMO: A simple treatment to reduce the activity of multiple sclerosis
https://sante.univ-nantes.fr/medias/photo/6094571199930015281_1727862266630-jpg
A ten-year study carried out by 36 research centers in France, including CR2TI's NEMO team, shows that high-dose vitamin D supplementation reduces multiple sclerosis progression at an early stage
This study, published in the Journal of the American Medical Association (JAMA) and highlighted in Le Figaro magazine, demonstrates that vitamin D effectively slows the progression of multiple sclerosis, an effect suspected since studies on mice in 2005.
Read the article on the ARSEP webpage here
Read the article on the ARSEP webpage here
Mis à jour le 17 mars 2025.